Sharechat Logo

Anatomy of a fiasco

Friday 16th February 2001

Text too small?
May 2000: Lion Nathan takes 15% stake and seeks 19.9% on-market.

August 2000: Lion raises stake to 28%

November 2000: Lion files notice of restricted transfer (NRT) indicating its intention to lift its stake to 51% at prices between $3.20 and $3.80.

December 3, 2000: Peter Masfen files NRT - same stake, same prices.

December 8, 2000: Commerce Commission clears Lion to buy 100%.

Mid-December 2000: ANZ Corporate Finance approaches Allied Domecq with Montana investment proposal, introduces Allied to Peter Masfen.

Wednesday, February 7, 2001, 4.39pm: Allied Domecq subsidiary Millstream Equities files NRT - 100% of Montana at $4.40 a share. Can buy shares on Friday.

Thursday, February 8:

  • 8.13 am: Montana independent directors recommend Millstream offer.
  • 9.20am: Lion files NRT raising offer price to $4.65-$4.80. As an insider under Stock Exchange listing rule 4.5.4, Lion can't buy shares until Monday.
  • 9.30am: Millstream announces market stand on Friday when NRT expires.
  • 1pm: Lion asks Stock Exchange market surveillance panel for a waiver from LR 4.5.4, requests ruling by 5pm.
  • 4.41: Panel "division" of Paul Bevin, Denis Wood and Sir Ian McKay grant waiver. Lion announces it will buy shares at $4.65-$4.80 from midnight. Lion's brokers, Credit Suisse First Boston, line up institutional shareholders.

Friday, February 8

  • 12.01am: Lion starts taking undertakings to sell from institutions
  • 8.16am: Lion has 46.46%, says will stand in the market for 4.5% at $4.65.

12.21pm: Montana independent directors say market surveillance panel won't revoke waiver. They "understand" Millstream would have counter-bid against Lion's latest offer.

Monday, February 12: Lion stands in the market for 5000 shares from each Montana shareholder at $4.65 a share. Secures 51% and control.

  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

Rua Bioscience Market Update
FSF - Fonterra announces interim leadership changes
April 29th Morning Report
NZK - Blue Endeavour Pilot Farm and Wellboat Update
TRU - FY 31 March 2026 Revenue and Results Guidance Achieved
FBU - Fletcher Building sale of Fletcher Reinforcing and Wire
April 28th Morning Report
RYM - Ryman Healthcare appoints new independent director
ikeGPS 4Q FY26 and Full Year FY26 Performance Update
HGH - Heartland trading update